Sign in

NCT03117946Completed

Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy

Source: ClinicalTrials.gov · Last updated 23 Jul 2026

Brief summary (registry, in English)

The aim of this study is to evaluate modulation of anti-tumor T cell responses in cancer patients treated by concomitant radiochemotherapy (i-RTCT)

Status (registry)
Completed
Study type
Interventional
Enrollment
136 (actual)
First submitted
13 Apr 2017
Start date
29 May 2017
Primary completion date
17 Aug 2023
Lead sponsor
Centre Hospitalier Universitaire de Besancon
NCT number
NCT03117946

What you commit to

  • Study type: Interventional
  • Participants enrolled: 136
  • From 29 May 2017 to the primary completion date, 17 Aug 2023
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Sequential radiochemotherapy, exclusive radiotherapy, or stereotactic radiotherapy
  • Patients under immunotherapy, chemotherapy or other immunosuppressive drugs (prednisone or prednisolone ≤ 10 mg/day is allowed)

Other illness

  • History of adjuvant radiochemotherapy for cancer treatment
  • HIV, hepatitis C or B virus
  • Patients with any medical or psychiatric condition or disease,

Other

  • Patients under guardianship, curatorship or under the protection of justice.

Who the study is looking for

  • Histologically confirmed NSCLC (Non Small Cell Lung Cancer) or SCLC (small cell lung cancer) OR histologically confirmed Head and neck cancer
  • Patient candidate to a first-line concomitant radiochemotherapy
  • Written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de Besançon
Coordinator of this site? Confirm its status
BesançonFranceUnknown status
Centre Georges François Leclerc
Coordinator of this site? Confirm its status
DijonFranceUnknown status
Hôpital Nord Franche-Comté
Coordinator of this site? Confirm its status
MontbéliardFranceUnknown status
Institut Jean Godinot
Coordinator of this site? Confirm its status
ReimsFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.